Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
13.00
+0.34 (2.69%)
At close: Aug 13, 2025, 4:00 PM
13.18
+0.18 (1.38%)
After-hours: Aug 13, 2025, 7:00 PM EDT
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $1.98 billion as of August 13, 2025. Its market cap has increased by 202.54% in one year.
Market Cap
1.98B
Enterprise Value
1.98B
1-Year Change
202.54%
Ranking
Category
Stock Price
$13.00
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $1.98B, a decrease of -58.54%. That is a compound annual growth rate of -13.37%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 574.04B |
Johnson & Johnson | 416.11B |
AbbVie | 350.91B |
UnitedHealth Group | 236.90B |
AstraZeneca | 232.33B |
Novartis AG | 230.64B |
Abbott Laboratories | 228.03B |
Novo Nordisk | 223.00B |